OrganOx, a leader in the field of organ preservation, has signed a 5 year agreement with Avidal Group GmbH to distribute the OrganOx metra in Germany, Austria and Switzerland.
As part of the agreement Avidal is committed to securing marketing approval for the CE marked metra in each of these 3 countries.
“ We are delighted to have signed up the Avidal Group to ensure the OrganOx metra is adopted in these 3 key European countries. We have been impressed with Avidal’s track record over many years in driving other innovative surgical and interventional products into these markets. With Avidal as our partner in Germany, Austria and Switzerland we look forward to establishing a significant presence in these countries in the coming years” said Craig Marshall, CEO of OrganOx Limited.
“We recognise the potential of the OrganOx metra to dramatically improve the utilisation of deceased donor livers, we see a huge opportunity for this product in the countries we serve. The marketing approval process in Germany is particularly complex, but it a process we at Avidal Group understand very well, and in the case of the OrganOx metra we actually began this process, in good faith, almost 12 months ago. We anticipate first sales into German liver transplant hospitals centres in Q4 of 2017” said Torsten Heilmann, CEO of Avidal Group GmbH.